Shanghai Pharma acquires U.S. Cardinal Health’s China business for $557m

Photo: Reuters

State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc’s China drug distribution business for $557 million, as it seeks to expand its distribution and retail network nationwide.

Continue reading this story with a subscription to DealStreetAsia.


Should your colleagues be reading this article too? Contact us for corporate subscriptions at